ImmunoForge Receives IND Approval for Phase 2 Clinical Trial of 'Pemziviptadil' for DMD Cardiomyopathy Treatment from FDA, and KF1601, a chronic myeloid leukemia treatment, phase 1 clinical trial IND approved by MFDS

SEOUL, South Korea, Jan. 14, 2025 /PRNewswire/ — ImmunoForge announced that it…

DJI Launches All-in-One Vlog Camera Drone with DJI Flip

New DJI Flip is DJI’s first drone to feature foldable, full-coverage propeller…

Triller Downloads Skyrocket Ahead of TikTok Ban

LOS ANGELES, Jan. 14, 2025 /PRNewswire/ — Triller, a creator-focused social media…

RuggON Launches VIKING II: Transforming Fleet Management with Unmatched Technology and Flexibility

Powered by Android 14 and Qualcomm® Snapdragon™ 6490 Octa-Core Processor, Engineered for…

MINISO Group Announces Completion of US$550 Million Equity Linked Securities

GUANGZHOU, China, Jan. 14, 2025 /PRNewswire/ — MINISO Group Holding Limited (NYSE:…

Bybit Card Partners with Entravel to Bring Discounted Luxury Travel to Its Users

DUBAI, UAE, Jan. 14, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency…

The Bicester Collection Brings the Unlock Her Future™ Prize 2025 to South Asia to Support the Next Wave of Female Social Entrepreneurs

For its third edition, the annual entrepreneurship programme aims to drive change…

Smartkem Recaps 2024 Achievements and Sets 2025 Goals

MANCHESTER, England, Jan. 14, 2025 /PRNewswire/ — Smartkem (Nasdaq: SMTK), which is…